Výsledky vyhledávání - "Dana Hossami"

The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States

Autor: Qian Ding, Dane Shiltz, Dana Hossami, Alison M Konieczny

Publikováno v: Expert Review of Pharmacoeconomics & Outcomes Research. 22:1231-1241

Previous U.S. economic burden estimates for rheumatoid arthritis (RA) varied from $85.6 to $148.1 billion annually. However, these estimates do not reflect comparative amounts spent on RA treatment options in addition to other medical expenditures. T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1620efe5e9831ca7f6b6d94fb52b49c
https://doi.org/10.1080/14737167.2022.2117690

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání